Please note that the contents in this webpage  are current as of the date of the announcement and the information including but not limited to the product availability, specification, prices, contacts, are subject to change without prior notice.

Nov 5, 2024
FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion
News ReleaseBio-CDMOCDMO
May 15, 2024
FUJIFILM Wako Pure Chemical Corporation Installs New Equipment to Triple Production Capacity of GMP-Compliant Raw Materials for Pharmaceutical Manufacturing (FUJIFILM Wako Pure Chemical)
Pharmaceuticals
Apr 12, 2024
Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
News ReleaseBio-CDMOCDMO
Apr 1, 2024
Fujifilm Launches "SYNAPSE Creative Space" Service in Japan
News ReleaseHealthcare IT
Feb 29, 2024
FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
News ReleaseBio-CDMOCDMOSustainability
Dec 5, 2023
Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities
News ReleaseBio-CDMOCDMOLife Sciences
Nov 8, 2023
FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility 
News ReleaseBio-CDMOCDMO
Jun 6, 2023
Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services 
News ReleaseBio-CDMOCDMO
Mar 31, 2023
Transfer of FUJIFILM Healthcare Systems’ electronic medical record and medical-receipt systems related business to PHC Holdings’ subsidiary
News ReleaseHealthcare IT
Dec 20, 2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
News ReleaseM&A, InvestmentHealthcare IT
Dec 14, 2022
Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund
News ReleaseRegenerative MedicineM&A, Investment
Oct 6, 2022
Fujifilm to establish its first Bio-CDMO site in Japan
News ReleaseBio-CDMOCDMOM&A, Investment
Jun 30, 2022
Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
News ReleaseBio-CDMOCDMOM&A, Investment
Apr 5, 2022
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
News ReleaseM&A, InvestmentBio-CDMOCDMO
Mar 22, 2022
Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business
Amendment in relation to a return of domestic marketing rights for a product
News ReleasePharmaceuticals
Jan 27, 2022
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
News ReleaseM&A, InvestmentBio-CDMOCDMO